Skip to main content
logo
Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.82
+0.35 (1.71%)
At close: Aug 25, 2026, 4:00 PM EDT
20.89
+0.07 (0.34%)
Pre-market: Aug 26, 2026, 7:22 AM EDT

Sabra Health Care REIT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
65.44155.61126.7113.76-77.61-113.26
Depreciation & Amortization
204.55182.12164.76177.27181.16192.5
Gain (Loss) on Sale of Assets
-24.223.52-2.176.6312.01-12.3
Gain (Loss) on Sale of Investments
----57.78164.13
Asset Writedown
3.667.3218.4714.3394.049.5
Stock-Based Compensation
13.1311.368.997.927.457.91
Income (Loss) on Equity Investments
13.895.846.3740.2527.96
Change in Accounts Receivable
-16.5-11.45-15.46-11.08-6.448.22
Change in Accounts Payable
7.811.6-7.098.34-13.2514.48
Other Operating Activities
15.13-4.310.996.8520.1953.31
Operating Cash Flow
371.57348.61310.54300.57315.73356.39
Operating Cash Flow Growth
9.66%12.26%3.32%-4.80%-11.41%0.43%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Acquisition of Real Estate Assets
-737.44-494.45-191.14-163.39-146.68-142.1
Sale of Real Estate Assets
178.6788.6496247.6295.3100.72
Net Sale / Acq. of Real Estate Assets
-558.77-405.82-95.1484.24-51.37-41.38
Investment in Marketable & Equity Securities
9.68.051.85-10.25-145.56-7.77
Other Investing Activities
0.296.052.385.8-0.78-
Investing Cash Flow
-334.97-377.96-109103.13-216.25-336.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-609.8114.612.19204.05791.52
Long-Term Debt Repaid
--502.09-2.03-106.32-81.27-767.66
Net Debt Issued (Repaid)
153.34107.7212.56-94.13122.7823.86
Issuance of Common Stock
251.28227.7886.12--308.71
Common Dividends Paid
-298.06-289.5-280.15-277.45-277.16-262.92
Total Dividends Paid
-298.06-289.5-280.15-277.45-277.16-262.92
Other Financing Activities
-6.55-5.24-0.09-38.72-7.33-39.51

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.080.39-0.36-0.610.270.03
Net Cash Flow
136.6911.819.62-7.21-61.9550.36

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
155.12309.78244.17254.3278.48344.75
Unlevered Free Cash Flow
227.64380.09315.91324.93144.4406.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
114.99110.96105.2102.4197.7285.46
Cash Income Tax Paid
1.51.51.391.671.661.84
Change in Working Capital
-8.7-9.85-22.55-2.73-19.6922.7
SEC Filings: 10-K · 10-Q